Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Very long-term survivors among patients with metastatic soft tissue sarcoma.
Carbonnaux M, Brahmi M, Schiffler C, Meeus P, Sunyach MP, Bouhamama A, Karanian M, Tirode F, Pissaloux D, Vaz G, Ray-Coquard I, Blay JY, Dufresne A. Carbonnaux M, et al. Among authors: vaz g. Cancer Med. 2019 Apr;8(4):1368-1378. doi: 10.1002/cam4.1931. Epub 2019 Mar 27. Cancer Med. 2019. PMID: 30916474 Free PMC article.
Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT).
Brahmi M, Cassier P, Dufresne A, Chabaud S, Karanian M, Meurgey A, Bouhamama A, Gouin F, Vaz G, Garret J, Sunyach MP, Dupré A, Marec-Berard P, Corradini N, Perol D, Ray-Coquard I, Blay JY. Brahmi M, et al. Among authors: vaz g. PLoS One. 2020 May 20;15(5):e0233046. doi: 10.1371/journal.pone.0233046. eCollection 2020. PLoS One. 2020. PMID: 32433669 Free PMC article.
Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort analysis.
Gouin F, Stoeckle E, Honoré C, Ropars M, Jafari M, Mattei JC, Rochwerger A, Carrere S, Waast D, Ferron G, Machiavello JC, Anract P, Marchal F, Sirveaux F, Marco O, Guiramand J, Paquette B, Di Marco A, Causeret S, Guilloit JM, Soibinet P, Tzanis D, Gimbergues P, Fiorenza F, Dujardin F, Le Nail LR, Ruzic JC, Chemin-Airiau C, Morelle M, Meeus P, Karanian M, Le Loarer F, Vaz G, Blay JY; NETSARC/RREPS and French Sarcoma Group-Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) networks. Gouin F, et al. Among authors: vaz g. BMC Cancer. 2022 Oct 3;22(1):1034. doi: 10.1186/s12885-022-10121-5. BMC Cancer. 2022. PMID: 36192725 Free PMC article.
Prognostic Factors for Local Recurrence after Cryoablation of Desmoid Tumors.
Bouhamama A, Wdowik Q, Grillet F, Brahmi M, Sunyach MP, Vaz G, Meeus P, Gouin F, Corradini N, Dufresne A, Chabaud S, Blay JY, Pilleul F. Bouhamama A, et al. Among authors: vaz g. J Vasc Interv Radiol. 2023 Sep;34(9):1538-1546. doi: 10.1016/j.jvir.2023.05.012. Epub 2023 May 12. J Vasc Interv Radiol. 2023. PMID: 37182669
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.
Blay JY, Piperno-Neumann S, Watson S, Dufresne A, Valentin T, Duffaud F, Toulmonde M, Italiano A, Bertucci F, Tlemsani C, Firmin N, Bompas E, Perrin C, Ropars M, Saada-Bouzid E, Dubray-Longeras P, Hervieu A, Lebbe C, Gantzer J, Chaigneau L, Fiorenza F, Rios M, Isambert N, Soibinet P, Boudou-Roquette P, Verret B, Ferron G, Ryckewaert T, Lebellec L, Brahmi M, Gouin F, Meeus P, Vaz G, Le Loarer F, Karanian M, De Pinieux G, Ducimetiere F, Chemin C, Morelle M, Le Cesne A, Penel N; NETSARC/REPPS/RESOS and French Sarcoma Group–Groupe d′Etude des Tumeurs Osseuses (GSF-GETO) networks. Blay JY, et al. Among authors: vaz g. Eur J Cancer. 2023 Oct;192:113262. doi: 10.1016/j.ejca.2023.113262. Epub 2023 Jul 29. Eur J Cancer. 2023. PMID: 37625241 Free article.
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
Blay JY, Tlemsani C, Toulmonde M, Italiano A, Rios M, Bompas E, Valentin T, Duffaud F, Le Nail LR, Watson S, Firmin N, Dubray-Longeras P, Ropars M, Perrin C, Hervieu A, Lebbe C, Saada-Bouzid E, Soibinet P, Fiorenza F, Bertucci F, Boudou P, Vaz G, Bonvalot S, Honoré C, Marec-Berard P, Minard V, Cleirec M, Biau D, Meeus P, Babinet A, Dumaine V, Carriere S, Fau M, Decanter G, Gouin F, Ngo C, Le Loarer F, Karanian M, Meurgey A, Dufresne A, Brahmi M, Chemin-Airiau C, Ducimetiere F, Penel N, Le Cesne A; NETSARC/REPPS/RESOS and French Sarcoma Group- Groupe d′Etude des Tumeurs Osseuses (GSF-GETO) networks. Blay JY, et al. Among authors: vaz g. Eur J Cancer. 2024 Jan;196:113454. doi: 10.1016/j.ejca.2023.113454. Epub 2023 Nov 23. Eur J Cancer. 2024. PMID: 38008029 Free article.
Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution.
Fayette J, Boyle H, Chabaud S, Favier B, Engel C, Cassier P, Thiesse P, Méeus P, Sunyach MP, Vaz G, Ray-Coquard I, Ranchère D, Decouvelaere AV, Alberti L, Pérol D, Blay JY. Fayette J, et al. Among authors: vaz g. Anticancer Drugs. 2010 Jan;21(1):113-9. doi: 10.1097/CAD.0b013e328333057b. Anticancer Drugs. 2010. PMID: 19887935 Clinical Trial.
154 results